dc.contributor.author | Roche, Nicolas | |
dc.contributor.author | Campbell, Jonathan D. | |
dc.contributor.author | Krishnan, Jerry A. | |
dc.contributor.author | Brusselle, Guy | |
dc.contributor.author | Chisholm, Alison | |
dc.contributor.author | Bjermer, Leif | |
dc.contributor.author | Thomas, Mike | |
dc.contributor.author | van Ganse, Eric | |
dc.contributor.author | van den Berge, Maarten | |
dc.contributor.author | Christoff, George | |
dc.contributor.author | Quint, Jennifer | |
dc.contributor.author | Papadopoulos, Nikolaos G. | |
dc.contributor.author | Price, David | |
dc.date.accessioned | 2019-08-22T09:10:05Z | |
dc.date.available | 2019-08-22T09:10:05Z | |
dc.date.issued | 2019-03-27 | |
dc.identifier | 146923343 | |
dc.identifier | 0997eb41-7927-4f39-81c0-6b5b4a3a2021 | |
dc.identifier | 30962875 | |
dc.identifier | 85063497772 | |
dc.identifier.citation | Roche , N , Campbell , J D , Krishnan , J A , Brusselle , G , Chisholm , A , Bjermer , L , Thomas , M , van Ganse , E , van den Berge , M , Christoff , G , Quint , J , Papadopoulos , N G & Price , D 2019 , ' Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT) : report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force ' , Clinical and Translational Allergy , vol. 9 , no. 1 , 20 . https://doi.org/10.1186/s13601-019-0255-x | en |
dc.identifier.issn | 2045-7022 | |
dc.identifier.other | RIS: urn:079C2A114FC3F54DF45E08F32B63E50F | |
dc.identifier.other | RIS: Roche2019 | |
dc.identifier.other | PubMedCentral: PMC6436229 | |
dc.identifier.uri | http://hdl.handle.net/2164/12751 | |
dc.description | Acknowledgements The authors would like to thank Katy Gallop and Sarah Acaster who contributed to the literature search and Zoe Mitchell who designed the web-based version of the tool. Funding This study was funded by the Respiratory Effectiveness Group (REG), and the European Academy of Allergy and Clinical Immunology (EAACI). Availability of data and materials The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. | en |
dc.format.extent | 17 | |
dc.format.extent | 1574337 | |
dc.format.extent | 465743 | |
dc.language.iso | eng | |
dc.relation.ispartof | Clinical and Translational Allergy | en |
dc.subject | asthma | en |
dc.subject | comparative effectiveness | en |
dc.subject | quality standards | en |
dc.subject | observational studies | en |
dc.subject | database | en |
dc.subject | R Medicine (General) | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R1 | en |
dc.title | Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT) : report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1186/s13601-019-0255-x | |
dc.identifier.vol | 9 | en |
dc.identifier.iss | 1 | en |